These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36099026)

  • 1. Cationic Chitosan/Pectin Polyelectrolyte Nanocapsules of Moxifloxacin as Novel Topical Management System for Bacterial Keratitis.
    Mohan P; Rangari VD; Kesavan K
    Curr Eye Res; 2022 Nov; 47(11):1498-1507. PubMed ID: 36099026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
    Dubey V; Mohan P; Dangi JS; Kesavan K
    Int J Biol Macromol; 2020 Jun; 152():1224-1232. PubMed ID: 31751741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy: Development, Characterization, and Pharmacodynamic Study.
    Mohan P; Kesavan K
    AAPS PharmSciTech; 2021 Jun; 22(5):195. PubMed ID: 34184117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxypropyl methacrylamide-based copolymeric nanoparticles loaded with moxifloxacin as a mucoadhesive, cornea-penetrating nanomedicine eye drop with enhanced therapeutic benefits in bacterial keratitis.
    Ch S; Mishra P; Bhatt H; Ghosh B; Roy S; Biswas S
    Colloids Surf B Biointerfaces; 2021 Dec; 208():112113. PubMed ID: 34562784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationized gelatin-sodium alginate polyelectrolyte nanoparticles encapsulating moxifloxacin as an eye drop to treat bacterial keratitis.
    Ch S; Paul M; Padaga SG; Ghosh B; Biswas S
    Int J Biol Macromol; 2024 Apr; 264(Pt 1):130457. PubMed ID: 38432265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-poly(lactide-co-glycolide)/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis.
    Ch S; Padaga SG; Ghosh B; Roy S; Biswas S
    Carbohydr Polym; 2023 Jul; 312():120822. PubMed ID: 37059521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis.
    Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G
    Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical synthesis of chitosan/silver nanocomposites films loaded with moxifloxacin: Their characterization and potential antibacterial activity.
    Shah A; Yameen MA; Fatima N; Murtaza G
    Int J Pharm; 2019 Apr; 561():19-34. PubMed ID: 30817984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
    Bin-Jumah M; Gilani SJ; Jahangir MA; Zafar A; Alshehri S; Yasir M; Kala C; Taleuzzaman M; Imam SS
    Int J Nanomedicine; 2020; 15():7861-7875. PubMed ID: 33116505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation.
    Kaskoos RA
    Int J Pharm Investig; 2014 Oct; 4(4):164-73. PubMed ID: 25426437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers:
    Polat HK; Kurt N; Aytekin E; Akdağ Çaylı Y; Bozdağ Pehlivan S; Çalış S
    J Ocul Pharmacol Ther; 2022; 38(6):412-423. PubMed ID: 35675672
    [No Abstract]   [Full Text] [Related]  

  • 12. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation.
    Mahor A; Prajapati SK; Verma A; Gupta R; Iyer AK; Kesharwani P
    J Colloid Interface Sci; 2016 Dec; 483():132-138. PubMed ID: 27552421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection.
    Sohrabi S; Haeri A; Mahboubi A; Mortazavi A; Dadashzadeh S
    Int J Biol Macromol; 2016 Apr; 85():625-33. PubMed ID: 26794314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating The Retention Potential of Chitosan Nanoparticulate Gel: Design, Development,
    Kaul S; Jain N; Pandey J; Nagaich U
    Recent Pat Antiinfect Drug Discov; 2020; 15(1):41-67. PubMed ID: 31612834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
    Fu T; Yi J; Lv S; Zhang B
    J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea.
    Gade S; Patel KK; Gupta C; Anjum MM; Deepika D; Agrawal AK; Singh S
    J Pharm Sci; 2019 Sep; 108(9):2905-2916. PubMed ID: 30978345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
    Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
    Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Improvement of the Efficacy of Moxifloxacin HCl for the Treatment of Bacterial Keratitis by the Formulation of Ocular Mucoadhesive Microspheres.
    Dandagi PM; Belekar AM; Mastiholimath VS; Gadad AP; Sontake VW; Salian PS
    Sci Pharm; 2013; 81(1):259-80. PubMed ID: 23641344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin.
    Sebastián-Morelló M; Calatayud-Pascual MA; Rodilla V; Balaguer-Fernández C; López-Castellano A
    Drug Deliv Transl Res; 2018 Feb; 8(1):132-139. PubMed ID: 29134554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus.
    Marino A; Blanco AR; Ginestra G; Nostro A; Bisignano G
    Int J Antimicrob Agents; 2016 Oct; 48(4):395-400. PubMed ID: 27554440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.